Yestar Healthcare Holdings Co (HKSE:02393) Inventories, Raw Materials & Components: HK$ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Yestar Healthcare Holdings Co Inventories, Raw Materials & Components?

Yestar Healthcare Holdings Co HKSE:02393 +4.55% Inventories, Raw Materials & Components is HK$ Mil as of Jun. 2026. The stock has 4 warning signs investors should review.

Yestar Healthcare Holdings Co's inventories, raw materials & components for the quarter that ended in Jun. 2026 was HK$ Mil.

Yestar Healthcare Holdings Co's quarterly raw materials increased from Jun. 2025 (HK$ Mil) to Dec. 2025 (HK$55 Mil) but then declined from Dec. 2025 (HK$55 Mil) to Jun. 2026 (HK$ Mil).

Yestar Healthcare Holdings Co's annual raw materials declined from Dec. 2023 (HK$63 Mil) to Dec. 2024 (HK$59 Mil) and declined from Dec. 2024 (HK$59 Mil) to Dec. 2025 (HK$55 Mil).

Yestar Healthcare Holdings Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Yestar Healthcare Holdings Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yestar Healthcare Holdings Co Inventories, Raw Materials & Components Chart

Yestar Healthcare Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.32 56.20 63.23 59.26 55.44

Yestar Healthcare Holdings Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 59.26 - 55.44 -

Yestar Healthcare Holdings Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of HK$ Mil mean?
Yestar Healthcare Holdings Co (HKSE:02393) has a Inventories, Raw Materials & Components of HK$ Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on Yestar Healthcare Holdings Co and its competitors.
Is Yestar Healthcare Holdings Co's Inventories, Raw Materials & Components too high?
Yestar Healthcare Holdings Co's current Inventories, Raw Materials & Components is HK$ Mil.
How does Yestar Healthcare Holdings Co's Inventories, Raw Materials & Components compare to ABT and SYK?
Yestar Healthcare Holdings Co's Inventories, Raw Materials & Components of HK$ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Yestar Healthcare Holdings Co and its competitors. Yestar Healthcare Holdings Co's current Inventories, Raw Materials & Components is HK$ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yestar Healthcare Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Yestar Healthcare Holdings Co (HKSE:02393) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.05, compared to a current price of HK$0.07 — trading 38% above its estimated fair value. The current Inventories, Raw Materials & Components is HK$ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Yestar Healthcare Holdings Co (HKSE:02393), the current Inventories, Raw Materials & Components is HK$ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yestar Healthcare Holdings Co Business Description

Address No. 1, Lane 388, Kang’an Road, Room 1210-1213, 12th Floor, Building T1, Pudong New District, Shanghai, CHN
Yestar Healthcare Holdings Co Ltd is engaged in the manufacture, distribution, and sale of medical imaging products, distribution of In Vitro Diagnostic (IVD) products, and manufacture and sale of dental films. The Group has two reportable operating segments: Imaging printing products segment, which includes the manufacture and sale of colour photographic paper, industrial NDT x-ray films and PWB films, and trading of imaging equipment; and Medical products and equipment segment, which generates maximum revenue and includes manufacture and sale of medical dry films, medical wet films and dental films, and sale of medical equipment and diagnostic reagents. The Group operates its business in Mainland China.